NOVARTIS CAPITAL P Profile

66989HAP3   99.97  0.00  0.00%   

Performance

Solid

 
Weak
 
Strong

Odds Of Default

Below Average

 
High
 
Low
NOVARTIS CAP CORP 1.75 percent 14Feb2025 is a Senior Unsecured Note issued by the corporate entity on the 11th of February 2020. NOVARTIS is trading at 99.97 as of the 26th of February 2025, a No Change since the beginning of the trading day. The bond's open price was 99.97. NOVARTIS has about a 29 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat solid performance during the last 90 days. Ratings for NOVARTIS CAPITAL P are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of January 2025 and ending today, the 26th of February 2025. Click here to learn more.

Moving together with NOVARTIS Bond

  0.72RXI iShares Global ConsumerPairCorr
  0.85MMM 3M CompanyPairCorr

Moving against NOVARTIS Bond

  0.76AA Alcoa CorpPairCorr
  0.56HPQ HP Inc Earnings Call TodayPairCorr
  0.5500108WAF7 AEP TEX INCPairCorr
  0.49TRV The Travelers CompaniesPairCorr
  0.45XOM Exxon Mobil CorpPairCorr
  0.44MSFT MicrosoftPairCorr

NOVARTIS Bond Highlights

Business ConcentrationNOVARTIS CAPITAL P Corporate Bond, Financial, Financial Services (View all Sectors)
Sub Product AssetCORP
Next Call Date14th of January 2025
Coupon Payment FrequencySemi-Annual
CallableYes
Sub Product Asset TypeCorporate Bond
NameNOVARTIS CAP CORP 1.75 percent 14Feb2025
C U S I P66989HAP3
Offering Date11th of February 2020
Coupon1.75
Debt TypeSenior Unsecured Note
I S I NUS66989HAP38
Yield To Maturity5.547
Price95.08
NOVARTIS CAPITAL P (66989HAP3) is traded in USA.

NOVARTIS CAPITAL P Risk Profiles

NOVARTIS Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in NOVARTIS without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Backtesting Now

   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Module

Other Information on Investing in NOVARTIS Bond

NOVARTIS financial ratios help investors to determine whether NOVARTIS Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NOVARTIS with respect to the benefits of owning NOVARTIS security.